xilis
Next generation technologies for precision medicine.
Next generation technologies for precision medicine.
Xilis is a biotechnology startup founded in 2019 with the slogan "Next generation technologies for precision medicine." The company is focused on developing next generation technologies for precision medicine and drug discovery, operating in the industries of biotechnology, health care, and pharmaceutical. The United States based company recently received a significant $19.00M Series A investment on 13 July 2022. The round was backed by a consortium of notable investors including Two Sigma Ventures, Felicis Ventures, GV, Duke Angel Network, Alexandria Venture Investments, Alix Ventures, Catalio Capital Management, EQT, FPV Ventures, Mubadala Capital Ventures. With this substantial investment and a focus on cutting-edge medical technologies, Xilis is well-positioned to make a meaningful impact in the field of precision medicine.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $19.00M | 10 |
|
13 Jul 2022 |
| Series A | $70.00M | - | 08 Jul 2021 | |
| Seed Round | Unknown | - | 05 May 2020 | |
| Seed Round | $3.00M | - | 10 Dec 2019 | |
| Pre Seed Round | Unknown | - | 17 Oct 2019 |
No recent news or press coverage available for xilis.
We care about your data, and we'd love to use cookies make your experience better.
